Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis.
about
Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugsDurable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.Targeting potassium channels Kv1.3 and KC a 3.1: routes to selective immunomodulators in autoimmune disorder treatment?Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitisKv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft modelThe Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for Immunosuppression.Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune DiseasesKv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis.Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseasesT Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 BlockersIon channels in innate and adaptive immunityClinical and immunological implications of increase in CD208+ dendritic cells in tonsils of patients with immunoglobulin A nephropathy.Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.Roles of lymphocyte kv1.3-channels in the pathogenesis of renal diseases and novel therapeutic implications of targeting the channels.Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies.Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840.Mechanism of functional interaction between potassium channel Kv1.3 and sodium channel NavBeta1 subunit.Overexpression of Delayed Rectifier K(+) Channels Promotes In situ Proliferation of Leukocytes in Rat Kidneys with Advanced Chronic Renal Failure.Effector memory T lymphocytes in renal disease.Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation - a pilot study.A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3.Proliferation of CD8-positive T cells in blood vessels of rat renal allografts.
P2860
Q28069399-081D52E0-E500-451A-AF13-185F62E196ACQ34277605-A83D806F-75EE-4B2B-9EB7-5F2B1C439C33Q34343254-EAC0E829-A3D5-42DA-BEE6-FB0C29331E1DQ34437894-27A52E77-EF78-418B-B45C-218BB0DDC46FQ35429501-EAC73073-9397-4278-83DA-3090D511A343Q35660234-4E3B6040-3402-4FA8-BC04-EF69F687B146Q35662935-7778D9C9-6CD3-4BFF-9FCA-38D518CF8332Q36016618-8166640C-BE96-4B72-97DD-AB73F5829BA3Q36097325-3495135F-0A83-43CF-9314-74C6AF9A69FEQ36255490-48F0EE5E-37DE-44E4-A020-3DDE4D0E9BBFQ36769825-AF8BC65E-93BB-4C77-A8A5-5ADD5B16F5F8Q37349702-9B7F4AFD-883D-4ACE-9254-85992928695EQ38237328-09F85E1B-FE18-4B1C-AA0F-9E9E28139B09Q38417868-7D036720-7DE3-488D-BDC1-78DCC3F7A3B5Q38553215-987947EC-3952-441A-A34A-A8F29CD753D5Q38658556-930D5159-D128-4AA6-A41E-72F994941B84Q38708465-9BC03C9D-9957-4699-8C5A-7942935C902AQ41719973-31EA2441-E5A4-4CB6-B19A-CE911265B058Q41788728-5CDE06AF-1D82-494E-8769-BD62B2F9FA28Q42186528-DA0A2B00-A0D0-43DF-9245-775D8D1EC023Q42548975-D0BB43C7-25AE-401C-8334-E7495A37F999Q46942213-31431666-D900-4EE2-A13C-2AF479C8B5E5Q52679662-2433C4BC-51F1-4323-883C-4BAA443F7FC3Q53227024-E5789E86-76DA-462F-AAF2-873AAD902B12
P2860
Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Voltage-gated potassium channe ...... t membrane glomerulonephritis.
@ast
Voltage-gated potassium channe ...... t membrane glomerulonephritis.
@en
Voltage-gated potassium channe ...... t membrane glomerulonephritis.
@nl
type
label
Voltage-gated potassium channe ...... t membrane glomerulonephritis.
@ast
Voltage-gated potassium channe ...... t membrane glomerulonephritis.
@en
Voltage-gated potassium channe ...... t membrane glomerulonephritis.
@nl
prefLabel
Voltage-gated potassium channe ...... t membrane glomerulonephritis.
@ast
Voltage-gated potassium channe ...... t membrane glomerulonephritis.
@en
Voltage-gated potassium channe ...... t membrane glomerulonephritis.
@nl
P2093
P2860
P1476
Voltage-gated potassium channe ...... t membrane glomerulonephritis.
@en
P2093
Hidehiko Fujinaka
Hiroo Kumagai
Keishi Higashi
Kojiro Yamamoto
Manabu Kinoshita
Muneharu Yamada
Ryota Hokari
Shigenobu Suzuki
Shuhji Seki
Soichiro Miura
P2860
P304
P356
10.1152/AJPRENAL.00374.2010
P577
2010-09-01T00:00:00Z